Skip to main content

Published locations for Ponesimod reduces annualized relapse rate, compared with teriflunomide

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ponesimod reduces annualized relapse rate, compared with teriflunomide

User login

  • Reset your password
  • /content/ponesimod-reduces-annualized-relapse-rate-compared-teriflunomide
  • /neurologyreviews/article/208034/multiple-sclerosis/ponesimod-reduces-annualized-relapse-rate
  • /multiplesclerosishub/article/208034/multiple-sclerosis/ponesimod-reduces-annualized-relapse-rate
  • /neurology/article/208034/multiple-sclerosis/ponesimod-reduces-annualized-relapse-rate-compared
  • /neurology/msresourcecenter/article/208034/multiple-sclerosis/ponesimod-reduces-annualized-relapse
  • /clinicalneurologynews/article/208034/multiple-sclerosis/ponesimod-reduces-annualized-relapse-rate